Publikationen: Stefaan Van Gool MD. PhD. Archive - IOZK

Beiträge

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

2024-03-28/in International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2024-03-28 / Biomedicines 2024 Mar;12(4)

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

2023-10-19/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2023-10-19 / Methods Cell Biol 2024;183:51-113

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

2023-07-28/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228

The Application of Evidence-Based Medicine in Individualized Medicine

2023-06-23/in International Publications, IOZK Veröffentlichungen /von 2023-06-23 / Biomedicines 2023 Jun;11(7)

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

2023-02-13/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2023-02-13 / Cancers (Basel) 2023 Feb;15(4)

Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences

2023-01-23/in Brain Tumors in Children, IOZK Aktuelles, IOZK Veröffentlichungen /von IOZK

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

2022-10-27/in International Publications, IOZK Veröffentlichungen /von 2022-10-27 / Int J Mol Sci 2022 Oct;23(21)

Posterpräsentation auf der Jahrestagung der Association for Cancer Immunotherapy

2022-06-02/in Glioblastoma, International Publications, IOZK bei Fachtagungen, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)

Poster presentation at the International Symposium on Pediatric Neuro-Oncology

2022-06-02/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2022-02-28 / Biomedicines 2022 Feb;10(3)

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

2022-02-16/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;